Charcot–Leyden Crystal Protein/Galectin-10 Is A Surrogate Biomarker of Eosinophilic Airway Inflammation in Asthma
- 3 June 2019
- journal article
- research article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (9) , 715-724
Abstract
Aim: Eosinophilic asthma is associated with more exacerbations and differential responses to treatment. The aim of this study was to assess if CLC/Gal-10 and MBP-1 are surrogate biomarkers of eosin...Keywords
Funding Information
- National Center for Research Resources (KL2RR029878)
This publication has 37 references indexed in Scilit:
- A sputum gene expression signature predicts oral corticosteroid response in asthmaEuropean Respiratory Journal, 2017
- Asthma phenotypes and endotypes: an evolving paradigm for classification.2013
- Galectin-10, a Potential Biomarker of Eosinophilic Airway InflammationPLOS ONE, 2012
- CLC– a novel susceptibility gene for allergic rhinitis?Allergy, 2010
- Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive functionBlood, 2007
- Comparative Proteomics of Nasal Fluid in Seasonal Allergic RhinitisJournal of Proteome Research, 2006
- Quality Control within the Asthma Clinical Research NetworkControlled Clinical Trials, 2001
- Crystal Structure of the Eosinophil Major Basic Protein at 1.8 ÅJournal of Biological Chemistry, 2001
- Sputum Induction as a Method of Analyzing Pulmonary Cells: Reproducibility and AcceptabilityJournal of Asthma, 1999
- Comparison of two methods of collecting induced sputum in asthmatic subjectsEuropean Respiratory Journal, 1996